[1] |
GANDHI N R, NUNN P, DHEDA K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis:a threat to global control of tuberculosis[J]. Lancet, 2010, 375(9728):1830-1843.
|
[2] |
ZHAO Y, XU S, WANG L, et al. National survey of drug-resistant tuberculosis in China[J]. N Engl J Med, 2012, 366(23):2161-2170.
|
[3] |
AKKAYA O, KURTOGLU M G. Comparison of conventional and molecular methods used for diagnosis of Mycobacterium tuberculosis in clinical samples[J]. Clin Lab, 2019,65(10).
|
[4] |
SETHI S, AGARWAL P, KHANEJA R, et al. Second-line drug resistance characterization in Mycobacterium tuberculosis by Genotype MTBDRsl assay[J]. J Epidemiol Glob Health, 2020, 10(1):42-45.
|
[5] |
TORREA G, NG K C S, VAN DEUN A, et al. Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance[J]. Sci Rep, 2019, 9(1):11826.
|
[6] |
SAKHAEE F, GHAZANFARI M, EBRAHIMZADEH N, et al. A comparative study of phenotypic and genotypic first-and second-line drug resistance testing of Mycobacterium tuberculosis[J]. Biologicals, 2017, 49:33-38.
|
[7] |
HUANG Z K, LUO Q, QING C, et al. Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis[J]. Int J Tuberc Lung Dis, 2016, 20(4):468-473.
|
[8] |
ADIKARAM C P, PERERA J, WIJESUNDERA S S. The manual mycobacteria growth indicator tube and the nitrate reductase assay for the rapid detection of rifampicin resistance of M. tuberculosis in low resource settings[J]. BMC Infect Dis, 2012, 12:326.
|
[9] |
AFFOLABI D, ODOUN M, SANOUSSI N, et al. Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples[J]. J Clin Microbiol, 2008, 46(10):3243-3245.
|
[10] |
World Health Organization. Policy guidance on drug-susceptibility testing(DST) of second-line antituberculosis drugs[EB/OL].(2008-07-15)[2020-01-01]. https://www.who.int/publications/i/item/WHO-HTM-TB-2008.392.
|
[11] |
COLL F, PHELAN J, HILL-CAWTHORNE G A, et al. Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis[J]. Nat Genet, 2018, 50(2):307-316.
|
[12] |
ISLAM M M, TAN Y, HAMEED H M A, et al. Prevalence and molecular characterization of amikacin resistance among Mycobacterium tuberculosis clinical isolates from southern China[J]. J Glob Antimicrob Resist, 2020,22:290-295.
|
[13] |
NDHLOVU V, MANDALA W, SLOAN D, et al. Evaluation of the efficacy of two methods for direct extraction of DNA from Mycobacterium tuberculosis sputum[J]. J Infect Dev Ctries, 2018, 12(12):1067-1072.
|
[14] |
DEVASIA R A, BLACKMAN A, MAY C, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis:an assessment of MGIT 960,MODS and nitrate reductase assay and fluoroquinolone cross-resistance[J]. J Antimicrob Chemother, 2009, 63(6):1173-1178.
|
[15] |
ZHAO L L, CHEN Y, LIU H C, et al. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China[J]. Antimicrob Agents Chemother, 2014, 58(4):1997-2005.
|
[16] |
LEMUS D, ECHEMENDÍA M, DÍAZ R, et al. Antituberculosis drug resistance in pulmonary isolates of Mycobacterium tuberculosis,Cuba 2012-2014[J]. MEDICC Rev, 2017, 19(1):10-15.
|
[17] |
MARTIN A, IMPERIALE B, RAVOLONANDRIANA P, et al. Prospective multicentre evaluation of the direct nitrate reductase assay for the rapid detection of extensively drug-resistant tuberculosis[J]. J Antimicrob Chemother, 2014, 69(2):441-444.
|
[18] |
World Health Organization. Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis:policy statement[EB/OL].(2011-09) https://apps.who.int/iris/bitstream/handle/10665/44601/9789241501620_eng.pdf?sequence=1&isAllowed=y.
|
[19] |
IKRAM A I, SATTI M L, LALANI F K, et al. Evaluation of nitrate reductase assay for early detection of multi and extensively drug resistance tuberculosis in our setup[J]. J Coll Physicians Surg Pak, 2018, 28(1):22-25.
|
[20] |
刘旭, 黄自坤, 杜晶辉. 核酸扩增检测法快速诊断胸膜结核的价值[J]. 中华结核和呼吸杂志, 2015, 38(10):741-745.
|
[21] |
BASTIAN I, SHEPHARD L, LUMB R, et al. Revised guidelines for Australian laboratories performing mycobacteriology testing[J]. Commun Dis Intell(2018), 2020,44.
|